Article
Causal Links Between Antibody-Mediated Immune Responses and Pancreatic Cancer Risk.
Endocrine, metabolic & immune disorders drug targets - 1 Jan 2026
Zou Xinyun, Feng Yicheng, Liu Pei, Zhang Ling, Shen Jinlan
Abstract excerpt
INTRODUCTION: Pancreatic cancer (PC) presents unique challenges to traditional immunotherapy due to its immunosuppressive microenvironment and low mutation burden. Research into antibody-mediated immune responses, which has been extensively applied in various cancer types, is also applicable to the study of pancreatic cancer. METHODS: Using public Genome-wide association study (GWAS) data and genetic instruments,...
Read the complete abstract on PubMedTopics
- Humans
- Pancreatic Neoplasms
- Genome-Wide Association Study
- Risk Factors
- Mendelian Randomization Analysis
- Genetic Predisposition to Disease
